报道称，记录显示，自2017年以来，在布法罗湾区域累计已发现近200具遗体，其中约40%死因不明。休斯顿当局正努力平息传言，安抚紧 张的当地居民。得州哈里斯县地方检察官肖恩·蒂尔向媒体表示，"我必须明确强调。没有任何迹象表明此地有连环杀手作案。（死者）有多 种死因，均与连环杀手无关。" 据报道，蒂尔将多数死亡案件归因于休斯顿"严重的无家可归问题"、心理健康及药物滥用问题。他解释说，"一旦进入湾流，逃生难度极 高。如果遇险的是药物中毒或醉酒者，情况将更加糟糕。"他补充说，"确实存在犯罪抛尸的情况，但这绝非普遍存在。" 【环球网报道】据美国《纽约邮报》当地时间12月30日报道，在美国得克萨斯州休斯顿布法罗湾河段，今年已累计发现34具遗体。报道 称，这引发多种猜测，有人认为这背后有连环杀手存在，当地官员则否认这种说法，称这与休斯顿"严重的无家可归问题"有关。 据美媒报道，休斯顿警方通报，上周在该河湾地区附近再次发现三具遗体。2025年在该区域发现的遗体数量累计已达34具。《纽约邮报》 称，有网络传言认为，这些死亡事件背后有连环杀手存在。游客胡安·桑多瓦尔接受美媒采访时说，"我认为是连环杀手所为。现在连内华达 州的' ...

转自：北京日报客户端 新华社北京12月29日电日本媒体发现，一款本应用来治疗糖尿病的药物如今被日本年轻人用来减肥。医 生警告说，这可能导致严重的健康风险。 一名22岁的女性说，她使用这种药物后出现了严重反应，包括恶心、低烧、情绪抑郁，"太难受了"。虽 然出现这些反应后她马上停了药，但症状还是持续了约三天。她食欲大幅下降，甚至有几天只能吃下半 块豆腐。 "大家不该随意使用这种药。" 她建议。 制药企业也发出提示指出，该药物在糖尿病治疗以外场景的安全性及有效性尚未得到证实。 她说，之所以选择药物减肥，是因为"我这一行很看重外表，我必须瘦"。 4日，人们在日本东京原宿的街道上行走。新华社记者张笑宇摄 2024年7月 一名35岁的准新娘也使用了这种药物，希望能在婚礼前减肥成功。她说，自己看到美容诊所一名护士在 社交媒体分享的减肥经历，于是前往诊所购买。 然而，这种药物在日本是用于糖尿病治疗而非减肥，一些盲目使用的人出现了严重副作用。 据日本共同社28日报道，许多年轻人从社交媒体上了解到一种糖尿病药物能减轻体重后，便盲目购买。 大阪一名20多岁女性说，她是从一个"网红"那里得知这种药，出于好奇和对减肥的渴望，她访问了一 ...

新京报记者 李聪 编辑 陈晓舒 校对 李立军 在经历两次住院之后，林可决定戒断普瑞巴林。 这是一款原本用于治疗神经性疼痛的处方药。她曾一次性吞下二十多片普瑞巴林，试图用药物迅速压住体内的焦虑、恐惧和失控感——"让自己暂时不用 面对现实"。 随后，她被送进急诊。凌晨两点，林可躺在病房的床上，盯着天花板，已经七十多个小时没有合眼。这是林可今年夏天第二次因为滥用普瑞巴林住院，距 离上一次，只隔了一个月。第一次是在8月，她的心率飙升到每分钟150次，晕倒在路上被室友送进急诊，那次也吃了二十几片。 此前，林可还过量服用右美沙芬等多种药物。后来，右美沙芬被列管、购买变得困难，普瑞巴林成为"替代品"。 林可的经历并非个案。近段时间，我国陆续出现普瑞巴林滥用的病例报告。2025年3月，湖南省脑科医院在国际期刊《精神病学前沿》发表一则病例报 告，记录了一名患者在长期、大剂量滥用普瑞巴林后形成依赖。其中提到，此前，中国尚未报告过普瑞巴林依赖病例。 2025年4月，《中国药物依赖性杂志》发表一则由山东省药品不良反应监测中心报告的病例，一位既往有滥用右美沙芬病史的未成年患者，在右美沙芬列 管后，开始使用其他药物替代滥用，其中普瑞巴林 ...

（来源：千龙网） 在经历两次住院之后，林可决定戒断普瑞巴林。 这是一款原本用于治疗神经性疼痛的处方药。她曾一次性吞下20多片普瑞巴林，试图用药物迅速压住体 内的焦虑、恐惧和失控感——"让自己暂时不用面对现实"。 随后，她被送进急诊。凌晨两点，林可躺在病房的床上，盯着天花板，已经70多个小时没有合眼。这是 林可今年夏天第二次因为滥用普瑞巴林住院，距离上一次，只隔了一个月。第一次是在8月，她的心率 飙升到每分钟150次，晕倒在路上被室友送进急诊，那次也吃了20几片。 此前，林可还过量服用右美沙芬等多种药物。后来，右美沙芬被列管，购买变得困难，普瑞巴林成 为"替代品"。 林可的经历并非个案。近段时间，我国陆续出现普瑞巴林滥用的病例报告。2025年3月，湖南省脑科医 院在国际期刊《精神病学前沿》发表一则病例报告，记录了一名患者在长期、大剂量滥用普瑞巴林后形 成依赖。其中提到，此前，中国尚未报告过普瑞巴林依赖病例。 2025年4月，《中国药物依赖性杂志》发表一则由山东省药品不良反应监测中心报告的病例，一位既往 有滥用右美沙芬病史的未成年患者，在右美沙芬列管后，开始使用其他药物替代滥用，其中普瑞巴林获 得最为便利，替代使 ...

每经记者｜岳楚鹏 兰素英 每经编辑｜高涵 一位20岁患者，因追求欣快感，每日服用80粒普瑞巴林。 一位30岁成瘾者，为改善睡眠和情绪，单次服用普瑞巴林剂量达4800毫克。 2025年3月和7月，湖南、上海分别报告了一例普瑞巴林滥用致成瘾病例，前者为国内首次。 但这并非个案。临床医生发现，越来越多的药物成瘾者，尤其是青少年，正通过网络购买普瑞巴林。而线上药店无需真实病历即可开处方，让这款处方药 轻易流入滥用群体手中。 《每日经济新闻》记者（以下简称每经记者）通过调查和多方采访，试图揭开普瑞巴林滥用的现状与风险。 0:00 / 4:33 国内首次报告普瑞巴林滥用致成瘾病例 普瑞巴林（原研药商品名乐瑞卡，Lyrica），是美国辉瑞研发的一款治疗癫痫、神经性疼痛和纤维肌痛的处方药，于2004年获得美国食品药品监督管理局 批准，并于2010年7月引入国内，现由晖致（辉瑞旗下Upjohn与仿制药企业Mylan合并而成）生产。 图片来源：视觉中国 2018年乐瑞卡专利到期后，国内多家厂商申请仿制。每经记者查询国家药品监督管理局官网发现，截至目前有超过50家国内厂商的普瑞巴林胶囊、缓释片 和口服液上市。 2025年3月，湖南 ...

Core Viewpoint - The article emphasizes the importance of distinguishing between influenza and the common cold, highlighting their differences in pathogens and symptom severity, and provides a practical medication list for families to prepare for the flu season [1]. Group 1: Differences Between Influenza and Common Cold - Influenza and common cold have similar symptoms but differ significantly in pathogens and severity [1]. Group 2: Medication Recommendations - Acetaminophen is recommended for alleviating fever symptoms caused by influenza, suitable for adults, pregnant women, and children aged 3 months and older, with dosage strictly calculated based on weight for infants and children [4]. - Ibuprofen is effective for fever reduction and relieving mild to moderate pain, appropriate for children over 6 months and adults, with specific formulations for children [4]. - Oseltamivir should be used as soon as influenza is diagnosed, ideally within 48 hours of onset, and is suitable for both types A and B influenza [6][7]. - Baloxavir marboxil is a viral RNA polymerase inhibitor for adults and children over 5 years old with influenza [8]. - Oral rehydration salts are recommended to prevent dehydration due to vomiting and diarrhea associated with influenza, suitable for both adults and children [9]. - Dextromethorphan is indicated for dry cough symptoms caused by influenza, suppressing the cough reflex [10]. - Expectorants can help thin mucus and promote its expulsion, beneficial for patients with thick phlegm [11]. Group 3: Medication Usage Guidelines - Antibiotics, such as amoxicillin, are ineffective against influenza unless there is a concurrent bacterial infection, and their misuse should be avoided [15]. - Special populations, including children, pregnant women, and elderly individuals with underlying conditions, should consult a doctor before using medications [15]. - Regularly check and clear expired medications from home medicine cabinets every 3-6 months to avoid using ineffective or harmful substances [17]. - Expired medications should not be discarded casually; they should be disposed of through community drug recycling points or hospital collection boxes to prevent environmental and health hazards [18].

Core Viewpoint - The article discusses the promotional activities for prescription drugs during the Double 11 shopping festival, highlighting the compliance concerns and regulatory challenges associated with these promotions [2][5][12]. Group 1: Promotional Activities - Major e-commerce platforms like JD.com, Alibaba, and Meituan have launched promotional campaigns that include discounts and subsidies for prescription drugs, with price reductions ranging from 10% to 20% [3][6]. - Specific examples include the price of the drug Retapamulin, which was reduced from 2,758 yuan to 1,999 yuan on JD.com, and from 3,034 yuan to 1,799.1 yuan on Alibaba [7][10]. - The promotional strategies include various forms such as "buy 300 yuan get 50 yuan off," "flash sales," and "lottery for free orders" [10][11]. Group 2: Regulatory Concerns - The promotion of prescription drugs may violate existing regulations, as certain promotional activities for prescription medications are explicitly prohibited [5][11]. - Legal experts indicate that the advertising of prescription drugs to the general public is restricted, and some promotional messages may constitute illegal advertising [5][13]. - The article raises concerns about the potential for misuse of prescription drugs due to the ease of obtaining prescriptions online, with reports of patients being able to acquire prescriptions without proper medical documentation [17][18]. Group 3: Market Trends - The demand for weight loss prescription drugs has surged, with sales of these medications increasing significantly during the Double 11 period, outpacing traditional consumer electronics like the iPhone 17 [6][10]. - The article notes that the drug Semaglutide has gained popularity, with its sales expected to surpass those of other leading weight loss medications [6][10]. - Platforms are also promoting "money-back guarantees" for weight loss drugs, which could further incentivize consumers to purchase these medications [15][16].

Core Points - Matthew Perry, known for his role as Chandler in "Friends," died from an acute overdose of ketamine, commonly referred to as "K powder" [1][3] - The drug dealer, Jasmin Sanga, admitted to providing the lethal dose of ketamine that led to Perry's death [1][3] Summary by Sections Incident Details - Perry purchased a significant amount of ketamine, including 25 vials for $6,000 just four days before his death [3] - He struggled with substance abuse for years, reportedly spending at least $9 million on rehabilitation efforts [3] Legal Proceedings - Sanga faces a maximum sentence of 65 years in prison and is one of five individuals charged in connection with Perry's death [3] - The case has revealed a large underground criminal network profiting from ketamine distribution [3] Industry Implications - The incident highlights the dangers of ketamine misuse, particularly in the context of addiction treatment [3] - Experts emphasize the need for awareness regarding the risks associated with substance abuse, likening it to a dangerous game of roulette [3]

Core Viewpoint - The article discusses the rising popularity and associated risks of purchasing generic Tirzepatide from Bangladesh through unofficial channels in China, highlighting the significant price difference compared to the original drug developed by Eli Lilly. Group 1: Product Overview - The price of the original Tirzepatide from Eli Lilly is approximately 405 yuan per unit, while the generic version from Bangladesh ranges from 190 to 260 yuan [1][2] - Tirzepatide has shown an average weight loss of 22.8 kg over 72 weeks in users, with global sales projected to reach 6.15 billion USD in the first quarter of 2025 [2] Group 2: Market Dynamics - The generic Tirzepatide is primarily sold through purchasing agents, with at least six different versions circulating in the Chinese market [2][3] - The lack of prescription and medical consultation among users raises concerns about the potential for serious adverse reactions [3][4] Group 3: User Demographics - Many users, like the case of a 23-year-old woman, are motivated by aesthetic goals rather than medical necessity, often using the drug without meeting the recommended BMI criteria [5][6][20] - There is a notable trend of individuals with normal BMI seeking weight loss through these drugs, indicating a broader societal issue regarding body image [22] Group 4: Regulatory and Safety Concerns - The article emphasizes the risks of drug quality and safety due to the unregulated nature of the purchasing process, including potential for counterfeit products and improper storage during transport [10][11][23] - The lack of clinical validation for these generic drugs in the Chinese population raises significant safety concerns, as they have not undergone the necessary trials to ensure efficacy and safety [19][24] Group 5: Legal Implications - The importation of these drugs without proper approval is illegal under Chinese law, with potential criminal liabilities for those involved in the distribution and sale of unapproved medications [26][27][28] - The article highlights the complexity of the legal landscape surrounding the importation and sale of these drugs, indicating that while personal importation may be tolerated, commercial activities are subject to strict penalties [27][28]

Core Viewpoint - The article discusses the rising trend of using a generic version of Tirzepatide, a weight loss drug developed by Eli Lilly, in China, highlighting the associated health risks and the legal implications of purchasing such drugs through unofficial channels [2][3][4]. Group 1: Product Overview - Tirzepatide, developed by Eli Lilly, shows an average weight loss of 22.8 kg after 72 weeks of use, with global sales projected to reach $6.15 billion by Q1 2025 [2]. - The generic version of Tirzepatide from Bangladesh is available in China due to patent exemptions, with at least six different versions circulating in the market [2][3]. Group 2: Market Dynamics - The price difference is a significant factor for consumers, with the original Eli Lilly version priced at approximately 405 RMB per dose, while the Bangladeshi version ranges from 190 to 260 RMB [2]. - The distribution of the Bangladeshi version primarily occurs through unofficial channels, with many consumers purchasing without prescriptions or proper medical guidance [3][7]. Group 3: Health Risks - Users of the Bangladeshi version often experience severe adverse reactions, including low blood sugar and acute gastrointestinal issues, due to self-medication without professional oversight [3][4][14]. - The lack of clinical validation for these generic drugs in the Chinese population raises concerns about their safety and efficacy [14]. Group 4: Legal and Regulatory Issues - The importation of unapproved drugs is strictly prohibited under Chinese law, and individuals involved in the distribution of such drugs may face severe legal consequences [16][17]. - The article highlights the potential for criminal charges related to the sale of unapproved medications, emphasizing the risks associated with purchasing from unofficial sources [16][17].